Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

pchop123 (76.62) Submitted: 6/6/2013 10:37:19 AM : Start Price: $3.13 CYCC Score: -2.60

could swing up substantially

zzlangerhans (99.76) Submitted: 4/18/2013 12:44:13 AM : Start Price: $4.95 CYCC Score: -43.00

Cyclacel is a swamp with a lot of traders' skeletons floating in the muck. The price chart since inception should tell you to approach the stock gingerly, if at all. I've already been burned once, but thankfully escaped with a small loss after ditching the hot potato close to the peak in 2012. That spike came thanks to some nimbly spun data from uninspiring DNA synthesis inhibitor sapacitabine.

While there are some midstage trials of sapacitabine in progress and CDK inhibitor seliciclib hasn't been officially put out to pasture, the only real hope for Cyclacel lies in the outcome of the SEAMLESS phase III trial of sapacitabine in elderly AML. At some point traders are going to start seeing Cyclacel as cheap at a 50M cap with a phase III cancer trial in progress, but given that the trial has only enrolled a third of the necessary 500 patients after more than two years it is likely still too early to risk a real investment. Meanwhile, the contamination of the capital structure with preferred stock and a history of unimpressive sapacitabine performance in midstage trials should provide further incentive to seek better opportunities for real life investments until SEAMLESS is closer to a binary catalyst.

toegar2000 (61.47) Submitted: 3/2/2013 10:25:20 AM : Start Price: $5.50 CYCC Score: -51.52

Looks good IMO

stainsolution (22.77) Submitted: 4/9/2012 9:52:19 AM : Start Price: $4.55 CYCC Score: -50.57

Small Cancer/Bio

RBuskey106 (33.54) Submitted: 3/21/2012 8:23:14 PM : Start Price: $4.40 CYCC Score: -45.97

Small cancer bio

nwarrior (< 20) Submitted: 7/27/2011 2:55:42 AM : Start Price: $8.26 CYCC Score: -85.87

This stock is poised to rise, already near it's 52 Week low. With a high insider net holding volume and low debt, this is an investment with great potential.

rwaddoups (< 20) Submitted: 1/3/2011 1:22:52 PM : Start Price: $10.50 CYCC Score: -98.89

yes

verbatum (< 20) Submitted: 10/5/2010 8:03:18 PM : Start Price: $11.34 CYCC Score: -113.63

Great Pipeline,Great PHASE II, Entering PHASE III, Shelf registered, Orphan Designation